» Articles » PMID: 9508010

Dietary Supplement Use by Women at Risk for Breast Cancer Recurrence. The Women's Healthy Eating and Living Study Group

Overview
Journal J Am Diet Assoc
Publisher Elsevier
Date 1998 Mar 21
PMID 9508010
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To develop a method of collecting, organizing, and analyzing information on nutrient and nonnutrient dietary supplement use by women at risk for breast cancer recurrence as a component of nutrition assessment and monitoring, and to describe the characteristics associated with dietary supplement use in this population at enrollment in a clinical trial to prevent breast cancer recurrence.

Design: Cross-sectional descriptive study design.

Subjects: Women diagnosed with breast cancer within the previous 4 years (n=435).

Analysis: Dietary supplements reported in four 24-hour dietary recalls were categorized according to primary nutrient and nonnutrient contents. Prevalence of dietary supplement use is described. Associations between supplement use and demographic and participant characteristics were examined using chi(2) analysis and logistic regression.

Results: Dietary supplement use was reported by 80.9% of the women. Increased likelihood of supplement use was associated with demographic (eg, older age, higher level of education, white race vs other ethnic groups) and personal (eg, lower body mass index, moderate alcohol consumption) characteristics. Use of vitamin C and related compounds, other nutrients (eg, n-3 fatty acids, evening primrose oil), and herbal products was inversely associated with months since diagnosis; use of miscellaneous supplements (eg, shark cartilage) was directly associated with more advanced stage at diagnosis.

Applications: Monitoring dietary supplement use is an important aspect of nutrition assessment, especially in populations with chronic health conditions or medical diagnoses. Demographic and personal characteristics, time passed since diagnosis, and stage of cancer at diagnosis are predictive of dietary supplement use by women at risk for breast cancer recurrence. Associations in this population may be present in other groups that are the object of nutrition intervention efforts.

Citing Articles

Dietary supplement intake in women with breast cancer before and after diagnosis: results from the SUCCESS C trial.

Hauner D, Mang A, Donik L, Schederecker F, Meyer D, Rack B BMC Cancer. 2024; 24(1):591.

PMID: 38750410 PMC: 11094984. DOI: 10.1186/s12885-024-12341-3.


In vitro evaluation of anticancer potentials of lupeol isolated from Elephantopus scaber L. on MCF-7 cell line.

Pitchai D, Roy A, Ignatius C J Adv Pharm Technol Res. 2014; 5(4):179-84.

PMID: 25364696 PMC: 4215481. DOI: 10.4103/2231-4040.143037.


The use of dietary supplements in oncology.

Frenkel M, Sierpina V Curr Oncol Rep. 2014; 16(11):411.

PMID: 25228351 DOI: 10.1007/s11912-014-0411-3.


Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study.

Greenlee H, Kwan M, Ergas I, Strizich G, Roh J, Wilson A BMC Cancer. 2014; 14:382.

PMID: 24884705 PMC: 4059470. DOI: 10.1186/1471-2407-14-382.


Use of Self-Care and Practitioner-Based Forms of Complementary and Alternative Medicine before and after a Diagnosis of Breast Cancer.

Link A, Gammon M, Jacobson J, Abrahamson P, Bradshaw P, Terry M Evid Based Complement Alternat Med. 2013; 2013:301549.

PMID: 23997792 PMC: 3753760. DOI: 10.1155/2013/301549.